Literature DB >> 12853392

Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults.

Gillian F Black1, Rosemary E Weir, Steven D Chaguluka, David Warndorff, Amelia C Crampin, Lorren Mwaungulu, Lifted Sichali, Sian Floyd, Lyn Bliss, Elizabeth Jarman, Linda Donovan, Peter Andersen, Warwick Britton, Glyn Hewinson, Kris Huygen, Jens Paulsen, Mahavir Singh, Ross Prestidge, Paul E M Fine, Hazel M Dockrell.   

Abstract

We have previously shown that young adults living in a rural area of northern Malawi showed greater gamma interferon (IFN-gamma) responses to purified protein derivatives (PPD) prepared from environmental mycobacteria than to PPD from Mycobacterium tuberculosis. In order to define the mycobacterial species to which individuals living in a rural African population have been exposed and sensitized, we tested T-cell recognition of recombinant and purified antigens from M. tuberculosis (38 kDa, MPT64, and ESAT-6), M. bovis (MPB70), M. bovis BCG (Ag85), and M. leprae (65 kDa, 35 kDa, and 18 kDa) in >600 non-M. bovis BCG-vaccinated young adults in the Karonga District of northern Malawi. IFN-gamma was measured by enzyme-linked immunosorbent assay (ELISA) in day 6 supernatants of diluted whole-blood cultures. The recombinant M. leprae 35-kDa and 18-kDa and purified native M. bovis BCG Ag85 antigens induced the highest percentages of responders, though both leprosy and bovine tuberculosis are now rare in this population. The M. tuberculosis antigens ESAT-6 and MPT64 and the M. bovis antigen MPB70 induced the lowest percentages of responders. One of the subjects subsequently developed extrapulmonary tuberculosis; this individual had a 15-mm-diameter reaction to the Mantoux test and responded to M. tuberculosis PPD, Ag85, MPT64, and ESAT-6 but not to any of the leprosy antigens. We conclude that in this rural African population, exposure to M. tuberculosis or M. bovis is much less frequent than exposure to environmental mycobacteria such as M. avium, which have antigens homologous to the M. leprae 35-kDa and 18-kDa antigens. M. tuberculosis ESAT-6 showed the strongest association with the size of the Mantoux skin test induration, suggesting that among the three M. tuberculosis antigens tested it provided the best indication of exposure to, or infection with, M. tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12853392      PMCID: PMC164276          DOI: 10.1128/cdli.10.4.602-611.2003

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  76 in total

1.  Human T-cell epitopes on the Mycobacterium tuberculosis secreted protein MPT64.

Authors:  P W Roche; C G Feng; W J Britton
Journal:  Scand J Immunol       Date:  1996-06       Impact factor: 3.487

2.  Geographic determinants of leprosy in Karonga District, Northern Malawi.

Authors:  J A Sterne; J M Pönnighaus; P E Fine; S S Malema
Journal:  Int J Epidemiol       Date:  1995-12       Impact factor: 7.196

3.  Heterogenous expression of the related MPB70 and MPB83 proteins distinguish various substrains of Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv.

Authors:  H G Wiker; S Nagai; R G Hewinson; W P Russell; M Harboe
Journal:  Scand J Immunol       Date:  1996-04       Impact factor: 3.487

4.  Detection of pulmonary and extrapulmonary tuberculosis patients with the 38-kilodalton antigen from Mycobacterium tuberculosis in a rapid membrane-based assay.

Authors:  A T Zhou; W L Ma; P Y Zhang; R A Cole
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

5.  Identification and characterization of the ESAT-6 homologue of Mycobacterium leprae and T-cell cross-reactivity with Mycobacterium tuberculosis.

Authors:  Annemieke Geluk; Krista E van Meijgaarden; Kees L M C Franken; Yanri W Subronto; Brigitte Wieles; Sandra M Arend; Elizabeth P Sampaio; Tjitske de Boer; William R Faber; Ben Naafs; Tom H M Ottenhoff
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

6.  Immunogenicity and protective efficacy of a tuberculosis DNA vaccine.

Authors:  K Huygen; J Content; O Denis; D L Montgomery; A M Yawman; R R Deck; C M DeWitt; I M Orme; S Baldwin; C D'Souza; A Drowart; E Lozes; P Vandenbussche; J P Van Vooren; M A Liu; J B Ulmer
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

7.  BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies.

Authors:  Gillian F Black; Rosemary E Weir; Sian Floyd; Lyn Bliss; David K Warndorff; Amelia C Crampin; Bagrey Ngwira; Lifted Sichali; Bernadette Nazareth; Jenefer M Blackwell; Keith Branson; Steven D Chaguluka; Linda Donovan; Elizabeth Jarman; Elizabeth King; Paul E M Fine; Hazel M Dockrell
Journal:  Lancet       Date:  2002-04-20       Impact factor: 79.321

Review 8.  Immunological and functional characterization of Mycobacterium leprae protein antigens: an overview.

Authors:  J E Thole; B Wieles; J E Clark-Curtiss; T H Ottenhoff; T F Rinke de Wit
Journal:  Mol Microbiol       Date:  1995-12       Impact factor: 3.501

9.  Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG.

Authors:  M Harboe; T Oettinger; H G Wiker; I Rosenkrands; P Andersen
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

10.  Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis.

Authors:  G G Mahairas; P J Sabo; M J Hickey; D C Singh; C K Stover
Journal:  J Bacteriol       Date:  1996-03       Impact factor: 3.490

View more
  16 in total

1.  Gamma interferon-based immunodiagnosis of tuberculosis: comparison between whole-blood and enzyme-linked immunospot methods.

Authors:  Elisabeth Schölvinck; Katalin A Wilkinson; Adam O Whelan; Adrian R Martineau; Michael Levin; Robert J Wilkinson
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

2.  What has Karonga taught us? Tuberculosis studied over three decades.

Authors:  A C Crampin; J R Glynn; P E M Fine
Journal:  Int J Tuberc Lung Dis       Date:  2009-02       Impact factor: 2.373

3.  Evaluation of T-cell responses to novel RD1- and RD2-encoded Mycobacterium tuberculosis gene products for specific detection of human tuberculosis infection.

Authors:  Xiao-Qing Liu; Davinder Dosanjh; Hansa Varia; Katie Ewer; Paul Cockle; Geoffrey Pasvol; Ajit Lalvani
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

4.  Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response.

Authors:  Benjamin M N Kagina; Brian Abel; Mark Bowmaker; Thomas J Scriba; Sebastian Gelderbloem; Erica Smit; Mzwandile Erasmus; Nonhlanhla Nene; Gerhard Walzl; Gillian Black; Gregory D Hussey; Anneke C Hesseling; Willem A Hanekom
Journal:  Vaccine       Date:  2009-07-17       Impact factor: 3.641

5.  The immune response to tuberculosis infection in the setting of Helicobacter pylori and helminth infections.

Authors:  S Perry; A H Chang; L Sanchez; S Yang; T D Haggerty; J Parsonnet
Journal:  Epidemiol Infect       Date:  2012-09-07       Impact factor: 2.451

6.  Distribution of environmental mycobacteria in Karonga District, northern Malawi.

Authors:  Benson Z Chilima; Ian M Clark; Sian Floyd; Paul E M Fine; Penny R Hirsch
Journal:  Appl Environ Microbiol       Date:  2006-04       Impact factor: 4.792

7.  Immunological consequences of intragenus conservation of Mycobacterium tuberculosis T-cell epitopes.

Authors:  Cecilia S Lindestam Arlehamn; Sinu Paul; Federico Mele; Charlie Huang; Jason A Greenbaum; Randi Vita; John Sidney; Bjoern Peters; Federica Sallusto; Alessandro Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-29       Impact factor: 11.205

8.  IFNgamma response to Mycobacterium tuberculosis, risk of infection and disease in household contacts of tuberculosis patients in Colombia.

Authors:  Helena del Corral; Sara C París; Nancy D Marín; Diana M Marín; Lucelly López; Hanna M Henao; Teresita Martínez; Liliana Villa; Luis F Barrera; Blanca L Ortiz; María E Ramírez; Carlos J Montes; María C Oquendo; Lisandra M Arango; Felipe Riaño; Carlos Aguirre; Alberto Bustamante; John T Belisle; Karen Dobos; Gloria I Mejía; Margarita R Giraldo; Patrick J Brennan; Jaime Robledo; María P Arbeláez; Carlos A Rojas; Luis F García
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

9.  MIG (CXCL9) is a more sensitive measure than IFN-gamma of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines.

Authors:  Tamara K Berthoud; Susanna J Dunachie; Stephen Todryk; Adrian V S Hill; Helen A Fletcher
Journal:  J Immunol Methods       Date:  2008-10-24       Impact factor: 2.303

10.  Biomarker changes associated with Tuberculin Skin Test (TST) conversion: a two-year longitudinal follow-up study in exposed household contacts.

Authors:  Rabia Hussain; Najeeha Talat; Firdaus Shahid; Ghaffar Dawood
Journal:  PLoS One       Date:  2009-10-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.